Revenue (Quarterly) Chart

View Revenue (Quarterly) for VASO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 19.36M
December 31, 2025 27.02M
September 30, 2025 22.66M
June 30, 2025 19.96M
March 31, 2025 19.46M
December 31, 2024 27.04M
September 30, 2024 20.77M
June 30, 2024 20.23M
March 31, 2024 18.74M
December 31, 2023 21.92M
September 30, 2023 19.45M
June 30, 2023 20.32M
March 31, 2023 19.04M
December 31, 2022 23.22M
September 30, 2022 19.83M
June 30, 2022 19.50M
March 31, 2022 17.01M
December 31, 2021 24.50M
September 30, 2021 18.43M
June 30, 2021 16.13M
March 31, 2021 16.52M
December 31, 2020 18.69M
September 30, 2020 17.43M
June 30, 2020 16.29M
March 31, 2020 17.23M
Date Value
December 31, 2019 23.95M
September 30, 2019 18.73M
June 30, 2019 17.54M
March 31, 2019 15.52M
December 31, 2018 19.24M
September 30, 2018 18.79M
June 30, 2018 18.42M
March 31, 2018 17.54M
December 31, 2017 20.52M
September 30, 2017 18.04M
June 30, 2017 17.85M
March 31, 2017 16.37M
December 31, 2016 19.29M
September 30, 2016 17.54M
June 30, 2016 18.21M
March 31, 2016 17.54M
December 31, 2015 21.38M
September 30, 2015 17.40M
June 30, 2015 10.84M
March 31, 2015 7.453M
December 31, 2014 12.36M
September 30, 2014 7.643M
June 30, 2014 7.864M
March 31, 2014 7.091M
December 31, 2013 10.10M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Global Innovative Platforms, Inc. 0.1065M
Omnicell, Inc. 309.88M
Carlsmed, Inc. 16.12M
MediXall Group, Inc. --
ECGI Holdings, Inc. 0.0625M